|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61P 17/06 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1478358 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03707846.6 |
| Date of filing the European patent application | 2003-02-11 | |
| (97) | Date of publication of the European application | 2004-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-03 |
| (46) | Date of publication of the claims translation | 2013-10-25 |
| (86) | Number | PCT/US2003/004103 |
| Date | 2003-02-11 |
| (87) | Number | WO 2003/068228 |
| Date | 2003-08-21 |
| (30) | Number | Date | Country code |
| 354950 P | 2002-02-11 | US |
| (72) |
DUMAS, Jacques, US
SCOTT, William, J., US
ELTING, James, US
HATOUM-MAKDAD, Holia, US
|
| (73) |
Bayer HealthCare LLC,
555 White Plains Road, Tarrytown, NY 10591,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Sorafenibo tozilatas, skirtas gydyti ligoms, būdingoms nenormaliai angiogenezei |
| Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis |
| Payment date | Validity (years) | Amount | |
| 2016-01-28 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2016-03-09 |